McKesson Corporation (MCK)
McKesson Corporation (MCK) Is a Trending Stock: Facts to Know Before Betting on It
Zacks.com users have recently been watching McKesson (MCK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
McKesson (MCK) Sees a More Significant Dip Than Broader Market: Some Facts to Know
The latest trading day saw McKesson (MCK) settling at $842.25, representing a -1.95% change from its previous close.
Is McKesson Stock Still A High-Conviction Compounder?
McKesson's net earnings increased at an average rate of 14.4% over the previous three years, while its earnings per share (EPS) grew by 19.6% annually in that same period. This 5.2% disparity indicates the additional value management has successfully secured for shareholders through a steadfast approach.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Investors Heavily Search McKesson Corporation (MCK): Here is What You Need to Know
McKesson (MCK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
McKesson (MCK) Advances But Underperforms Market: Key Facts
The latest trading day saw McKesson (MCK) settling at $871.18, representing a +1.7% change from its previous close.
Will McKesson (MCK) Beat Estimates Again in Its Next Earnings Report?
McKesson (MCK) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
McKesson (MCK) Outperforms Broader Market: What You Need to Know
In the closing of the recent trading day, McKesson (MCK) stood at $884.28, denoting a +1.37% move from the preceding trading day.
Here is What to Know Beyond Why McKesson Corporation (MCK) is a Trending Stock
McKesson (MCK) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Cardinal Health vs. McKesson: Which Healthcare Giant Is the Smarter Bet?
CAH's turnaround gains traction with strong earnings growth and margin expansion, outpacing MCK's steady performance outlook.
Here's Why You Should Add McKesson Stock to Your Portfolio Now
McKesson's strong oncology, GLP-1, and biopharma growth fuel earnings momentum, but margin pressure and segment volatility remain key watch points.
McKesson Corporation (MCK) is Attracting Investor Attention: Here is What You Should Know
Recently, Zacks.com users have been paying close attention to McKesson (MCK). This makes it worthwhile to examine what the stock has in store.
